TAPO in first‐line osimertinib therapy and continuation of osimertinib by Chihiro Mimura, Kazumi Kaneshiro, Shodai Fujimoto, Ryota Dokuni, Natsuhiko Iwamoto, Kanoko Matsumura, Yukihisa Hatakeyama, Yuko Kono, Motoko Tachihara

Get full text